Literature DB >> 15490145

Comparative imaging of differential pulmonary blood flow in patients with congenital heart disease: magnetic resonance imaging versus lung perfusion scintigraphy.

Kevin S Roman1, Christian J Kellenberger, Saqba Farooq, Christopher K MacGowan, David L Gilday, Shi-Joon Yoo.   

Abstract

BACKGROUND: Lung perfusion scintigraphy is considered the gold standard to assess differential pulmonary blood flow while magnetic resonance (MR) has been shown to be an accurate alternative in some studies.
OBJECTIVE: The purpose of the study was to assess the accuracy of phase contrast magnetic resonance (PC-MR) in measuring pulmonary blood flow ratio compared with lung perfusion scintigraphy in patients with complex pulmonary artery anatomy or pulmonary hypertension and to document reasons for discrepant results.
MATERIALS AND METHODS: We identified 25 cases of congenital heart disease between January 2000 and 2003, in whom both techniques of assessing pulmonary blood flow were performed within a 6-month period without an interim surgical or transcatheter intervention. The study group included cases with branch pulmonary artery stenosis, intracardiac shunts, single ventricle circulation, pulmonary venous anomalies and conotruncal defects. The mean age at study was 5.7 years (range 0.33-12) with a mean weight of 20.3 kg (range 6.5-53.6). The two methods were compared using a Bland-Altman analysis, and the Pearson correlation coefficient was calculated using the lung scan as the gold standard. Discrepant results were examined by reviewing the source images to elucidate reasons for error by MR.
RESULTS: Bland-Altman analysis comparing right pulmonary artery (RPA) blood flow percentage, as measured by each modality, showed a mean difference of 1.43+/-9.8 (95% limits of agreement: -17.8, 20.6) with a correlation coefficient of r=0.84, P<0.0001. In six (24%) cases a large difference (>10%) was found with a mean difference between techniques of 17.9%. The reasons for discrepant results included MR artifacts, dephasing owing to turbulent flow, site of data acquisition and lobar lung collapse.
CONCLUSION: When using PC-MR to assess pulmonary blood flow ratio, important technical errors occur in a significant proportion of patients who have abnormal pulmonary artery anatomy or pulmonary hypertension. If these technical errors are avoided, PC-MR is able to supply both anatomic and quantitative functional information in this patient population.

Entities:  

Mesh:

Year:  2004        PMID: 15490145     DOI: 10.1007/s00247-004-1344-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  23 in total

1.  Computational fluid dynamic and magnetic resonance analyses of flow distribution between the lungs after total cavopulmonary connection.

Authors:  F Migliavacca; P J Kilner; G Pennati; G Dubini; R Pietrabissa; R Fumero; M R de Leval
Journal:  IEEE Trans Biomed Eng       Date:  1999-04       Impact factor: 4.538

2.  Lung perfusion scintigraphy in patients with congenital heart disease: sensitivity and important pitfalls.

Authors:  A E Boothroyd; E A McDonald; H Carty
Journal:  Nucl Med Commun       Date:  1996-01       Impact factor: 1.690

3.  Normal three-dimensional pulmonary artery flow determined by phase contrast magnetic resonance imaging.

Authors:  V L Morgan; R J Roselli; C H Lorenz
Journal:  Ann Biomed Eng       Date:  1998 Jul-Aug       Impact factor: 3.934

4.  In vivo evaluation of Fontan pathway flow dynamics by multidimensional phase-velocity magnetic resonance imaging.

Authors:  E Be'eri; S E Maier; M J Landzberg; T Chung; T Geva
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

5.  Lung scan in cardiopulmonary disease. I. Tetralogy of Fallot.

Authors:  C Y Lin
Journal:  J Thorac Cardiovasc Surg       Date:  1971-03       Impact factor: 5.209

6.  Quantitative lung perfusion scintigraphy in postoperative evaluation of congenital right ventricular outflow tract obstructive lesions.

Authors:  J H Kim; D S Lee; J K Chung; M C Lee; Y W Kim; Y S Yun; K M Yeon; C S Koh
Journal:  Clin Nucl Med       Date:  1996-06       Impact factor: 7.794

7.  Flow during exercise in the total cavopulmonary connection measured by magnetic resonance velocity mapping.

Authors:  E M Pedersen; E V Stenbøg; T Fründ; K Houlind; O Kromann; K E Sørensen; K Emmertsen; V E Hjortdal
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

8.  Pulmonary blood supply in bidirectional cavopulmonary anastomosis with pulsatile pulmonary blood flow: quantitative analysis using radionuclide angiocardiography.

Authors:  O Reich; P Horváth; C Ruth; M Krejcír; J Skovránek
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

9.  Perfusion lung scan in patients operated for transposition of the great arteries.

Authors:  C Houzard; M Andre; S Guilhen; P Thivolle; M Berger
Journal:  Clin Nucl Med       Date:  1989-04       Impact factor: 7.794

10.  Radionuclide evaluation of lung perfusion after the Fontan procedure.

Authors:  S del Torso; O Milanesi; F Bui; E Benetti; G Stellin; A Mazzucco; L Daliento; G Svaluto Moreolo; P A Pellegrino
Journal:  Int J Cardiol       Date:  1988-07       Impact factor: 4.164

View more
  17 in total

1.  Increasing the accuracy of lung perfusion scintigraphy in children with bidirectional Glenn circulation.

Authors:  Yutaka Fukuda; Nobuo Momoi; Masaki Mitomo; Yoshimichi Aoyagi; Kisei Endo; Ayumi Matsumoto; Mitsuaki Hosoya
Journal:  Pediatr Radiol       Date:  2010-05-26

2.  Preoperative assessment and follow-up of congenital abnormalities of the pulmonary arteries using CT and MRI.

Authors:  Sebastian Ley; Julia Zaporozhan; Raoul Arnold; Joachim Eichhorn; Jens-Peter Schenk; Herbert Ulmer; Karl-Friedrich Kreitner; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2006-06-24       Impact factor: 5.315

3.  Effects of pulmonary regurgitation on distensibility and flow of the branch pulmonary arteries in tetralogy of Fallot.

Authors:  Eva M Voser; Christian J Kellenberger; Emanuela R Valsangiacomo Buechel
Journal:  Pediatr Cardiol       Date:  2013-01-06       Impact factor: 1.655

4.  Computed tomography pulmonary vascular volume ratio in children and young adults with congenital heart disease: the effect of cardiac phase.

Authors:  Hyun Woo Goo
Journal:  Pediatr Radiol       Date:  2018-03-23

5.  Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging.

Authors:  S Sridharan; G Derrick; J Deanfield; A M Taylor
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

6.  Assessment of pulmonary veins after atrio-pericardial anastomosis by cardiovascular magnetic resonance.

Authors:  Steven C Greenway; Shi-Joon Yoo; Giedrius Baliulis; Christopher Caldarone; John Coles; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-21       Impact factor: 5.364

Review 7.  The emerging clinical role of cardiovascular magnetic resonance imaging.

Authors:  Andreas Kumar; David J Patton; Matthias G Friedrich
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

8.  Pulmonary vascular volume ratio measured by cardiac computed tomography in children and young adults with congenital heart disease: comparison with lung perfusion scintigraphy.

Authors:  Hyun Woo Goo; Sang Hyub Park
Journal:  Pediatr Radiol       Date:  2017-06-23

Review 9.  Additional value and new insights by four-dimensional flow magnetic resonance imaging in congenital heart disease: application in neonates and young children.

Authors:  Julia Geiger; Fraser M Callaghan; Barbara E U Burkhardt; Emanuela R Valsangiacomo Buechel; Christian J Kellenberger
Journal:  Pediatr Radiol       Date:  2020-12-11

10.  Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease.

Authors:  Sohrab Fratz; Taylor Chung; Gerald F Greil; Margaret M Samyn; Andrew M Taylor; Emanuela R Valsangiacomo Buechel; Shi-Joon Yoo; Andrew J Powell
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-13       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.